| Autor: |
Themistoklis, Konstantinos, Korfias, Stefanos, Kalyvas, Aristotelis, Boutos, Nikolaos, Boviatsis, Konstantinos, Giakoumettis, Dimitrios, Vlachakis, Eustathios, Themistocleous, Marios, Sakas, Damianos |
| Zdroj: |
Stereotactic & Functional Neurosurgery; 2016 Supplement 1, Vol. 94, p131-131, 2/3p |
| Abstrakt: |
Objectives: Presentation of a case series of 3 patients suffering from intractable spasticity, treated with intrathecal baclofen therapy. A new 'hybrid' pump (Siromedes 20 ml, Tricumed) was implanted in all patients, during the period from November 2015 to January 2016. Methods: a) A 30 year old female patient developed spastic right hemiplegia after a road traffic accident in 2004. She was treated with intrathecal baclofen therapy until the depletion of her programmable pump. In November 2015 she underwent surgical substitution of her previous pump with the new 'hybrid' pump. b) A 68 year old male patient developed spastic right hemiparesis after several ischemic episodes. He was receiving intrathecal baclofen therapy with a programmable pump since 2009. His old pump was depleted and replaced with the new 'hybrid' pump. c) A 17 year old male patient was suffering from severe spastic tetraparesis due to cerebral palsy. He underwent implantation of the new 'hybrid' pump. Results: The post-operative period was smooth for all three patients, with spasticity efficiently alleviated immediately after the initiation of baclofen therapy. The new baclofen pump represents a unique 'hybrid' mode of function, since it can be programmable for at least 8 years and thereafter continues to operate for a long period as a constant flow pump. Conclusions: The new 'hybrid' pump appears to be a safe and efficient alternative for intrathecal baclofen therapy. All 3 patients had an uncomplicated follow up period of 5 months or more. Longer follow-up periods and a larger patients sample are necessary for conclusive results. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
